
Betsy Ladyzhets spoke with Dr. Monica Bertagnolli, director of the National Institutes of Health (NIH), in a wide-ranging interview discussing the agency’s efforts to further research into Long Covid and related diseases. In the interview, Bertagnolli described a new phase of RECOVER, called Treating Long Covid, which responds to the Long Covid community’s criticism with…

Last week, Sen. Bernie Sanders introduced the Long Covid Research Moonshot Act of 2024. The bill allocates $1 billion in federal funding per year for the next 10 years for Long Covid research, treatments, public health education, and expanded healthcare. A draft version of the Act received thousands of comments from the Long Covid community…

The field of Long Covid research reached a major milestone last week with the release of a new report from the National Academies of Sciences, Engineering, and Medicine (NASEM) outlining a working definition of the disease.

In February 2021, the National Institutes of Health launched a new $1 billion initiative to study Long Covid, a chronic disease that has changed the lives of millions of Americans. Three years later, the NIH initiative, called RECOVER, has not met these goals, according to a detailed review of budget and planning documents obtained through…

Last week, a delegation organized by the grassroots advocacy group the Long Covid Campaign traveled to Washington D.C., asking Senate leaders to accelerate over a billion dollars in funding for Long Covid research with the Biden administration’s fiscal year 2025 budget for the National Institutes of Health (NIH). The advocates made themselves known in the…

Last week, Senator Bernie Sanders proposed a “moonshot” for Long Covid, which would allocate one billion dollars a year for the next 10 years to mandatory research into the disease. The Senator and the United Senate Committee on Health, Education, Labor, and Pensions (HELP) are currently seeking email feedback on a draft of this legislation,…

Research updates for the week of April 2 include a new NIH study about Havana Syndrome that parallels the agency’s recent ME paper, a Covid-19 antibody that may cause some Long Covid symptoms, and an upcoming clinical trial.

After NIH’s intramural ME study was published last month in the journal Nature Communications, some patient-advocates and experts in the ME community say their worst fears about this $8 million, eight-year research project were realized. In interviews with The Sick Times, advocates and experts shared concerns about which patients were included in the research, the…





advocacy arts CDC clinical trials commentary COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health research update science Trump administration updates and events vaccines wastewater surveillance